SO YOU DRIVE to the local park for your morning walk, drive and take a Metro to your office, where you grab the lift to the third floor, and then you repeat the commute in the evening. If you have to queue up for an autorickshaw, you crib about last-mile connectivity to your doorstep, instead of walking that mile.
That’s rising urbanisation and sedentary lifestyles for you. The bane of modern India. But they are a boon for pharmaceutical companies such as Eli Lilly & Co, whose 146-year history has been powered by a list of firsts: the first treatment for pernicious anaemia, the first mass-produced antibiotic, the mass-produced Salk polio vaccine, human insulin, and pills for clinical depression and schizophrenia, among others.
Lilly is now betting that its drugs for obesity and diabetes will power its revenues into a higher trajectory. Especially as obesity and diabetes are like the proverbial chicken and egg situation: which came first? Lilly’s portfolio also has your heart covered (obesity and diabetes can get your heart).
RESPONDING TO THE DUAL CRISIS
US-based Lilly is no stranger to India. In 1993, it set up a unit to bring its treatments for diabetes, a range of cancers, osteoporosis, rheumatoid arthritis, men’s health, and growth hormone deficiency.
Now, it aims to bring to India its hugely successful drug Mounjaro that is used to treat Type 2 diabetes and as an anti-obesity drug for adults. In the US, Lilly has launched two different brands: Zepbound for obesity; and Mounjaro for Type 2 diabetes. In both, the active ingredient is tirzepatide. Mounjaro’s revenue exceeded $5 billion in 2023, its first full year on the market.
According to the FDA, approximately 70% of American adults are obese or overweight, and many of those overweight have a weight-related condition.
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber ? Sign In
This story is from the {{IssueName}} edition of {{MagazineName}}.
Start your 7-day Magzter GOLD free trial to access thousands of curated premium stories, and 9,000+ magazines and newspapers.
Already a subscriber? Sign In
"IF ANYONE WANTS TO INVEST, COME TO HYDERABAD"
Telangana CM Revanth Reddy's global ambitions, AI, green energy, and how Hyderabad is positioning itself as a premier business and innovation hub
Where Food Meets Magic
THE FOOD AT THE ROCA BROTHERS' RESTAURANT IN GIRONA TRANSCENDS THE ORDINARY TO BECOME PURE MAGIC
"INDIA SHOULD CONSIDER LAND POOLING MODEL"
Andhra Pradesh (AP) minister Nara Lokesh talks about what governments can learn from the state about overcoming the land availability challenge
Breaking Barriers: The Extraordinary Journey of Pulkit Prakash
In an era where success often seems predetermined by privilege, Pulkit Prakash's journey from modest beginnings to legal eminence challenges conventional narratives. His remarkable transformation into the founding partner of Niti Bodh, a prestigious law firm, demonstrates how unwavering determination can reshape destinies.
"Keep the company's imperatives in mind first"
Westlife Foodworld Limited is a fast food restaurant holding company
Beyond the Scalpel: How Dr. Unmesh Takalkar Revolutionized Healthcare in Central Maharashtra
In an era where medical excellence often leads to overseas opportunities, one doctor chose a different path - transforming his homeland's healthcare landscape instead of seeking personal fortune abroad. Dr. Unmesh Vidyadhar Takalkar's journey from a bright medical student to a pioneering healthcare visionary in Marathwada stands as a testament to the power of purpose-driven leadership.
"Fils WILL MAKE A COMEBACK, MAYBE THIS YEAR"
Veteran investor Madhusudan Kela, Founder of MK Ventures, on Union Budget 2025-26, the future trajectory of the market, the Indian economy and more
"TAX CUT TO PUT MONEY INTO PEOPLES' HANDS"
Tuhin Kanta Pandey, Finance and Revenue Secretary, and Arunish Chawla, Secretary of DIPAM, explain the macro philosophy of the Budget
A BONANZA FOR THE MIDDLE CLASS
THE GOVERNMENT INCREASED THE TAX EXEMPTION LIMIT TO 12 LAKH AND REVISED RATES LOWER UNDER THE NEW TAX REGIME IN THE BUDGET FOR FY26. WITH A NEW INCOME TAX BILL ON THE WAY, WHAT DO THE MEASURES MEAN FOR TAXPAYERS?
Expect Private Investment Cycle To Pick Up
The government's budgetary strategy focusses on modification and moderation, a fine balance between the long term and the short term
